Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials.
J Diabetes Complications
; 37(8): 108529, 2023 08.
Article
de En
| MEDLINE
| ID: mdl-37301063
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Diabète de type 2
/
Hypoglycémiants
Type d'étude:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
/
Systematic_reviews
Limites:
Humans
Langue:
En
Journal:
J Diabetes Complications
Sujet du journal:
ENDOCRINOLOGIA
Année:
2023
Type de document:
Article